3D Breast Ultrasound Elastography in Patients Under Neoadjuvant Chemotherapy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01531036 |
Recruitment Status :
Completed
First Posted : February 10, 2012
Last Update Posted : February 25, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Malignant Breast Tumours | Device: 3D Ultrasound elastography by means of shear wave propagation into breast tissue | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 33 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Diagnostic |
Official Title: | Imagerie 3D d'élasticité du Sein Par échographie Ultrarapide au Cours d'un Traitement Par chimiothérapie néoadjuvante. |
Study Start Date : | December 2010 |
Actual Primary Completion Date : | November 2012 |
Actual Study Completion Date : | November 2012 |

Arm | Intervention/treatment |
---|---|
Experimental: shear wave imaging
Single arm study evaluating breast 3D elastography by means of shear wave propagation into breast tissue.
|
Device: 3D Ultrasound elastography by means of shear wave propagation into breast tissue
Aixplorer Supersonic Imagine Ultrasound System with 3D probe for real-time elastography
Other Name: Aixplorer Supersonic Imagine |
- 3D volumetric elasticity measurements [ Time Frame: 10min ]An utrafast shear wave imaging 3-plane acquisition provides several frames of breast lesion elasticity, that are reconstructed by means of a dedicated software thus permitting the direct volumetric elasticity measurements in kPa

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients having already undergone a breast MRI
- Patients presenting with breast lesions measuring between20-50mm in ultrasound
Exclusion Criteria:
- Multifocal lesions
- History of breast cancer
- Breast implants
- Inflammatory breast disease
- Pregnancy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01531036
France | |
Curie Cancer Institute | |
Paris, France, 75005 |
Principal Investigator: | Alexandra Athanasiou, MD | Curie Cancer Institute |
Responsible Party: | Institut National de la Santé Et de la Recherche Médicale, France |
ClinicalTrials.gov Identifier: | NCT01531036 |
Other Study ID Numbers: |
C10-02 2010-A00663-36 ( Registry Identifier: IDRCB ) |
First Posted: | February 10, 2012 Key Record Dates |
Last Update Posted: | February 25, 2016 |
Last Verified: | February 2016 |
Breast Neoplasms Neoplasms by Site Neoplasms Breast Diseases Skin Diseases |